• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Market characteristics o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2019 o Market outlook: Forecast for 2019 - 2024 • Five Forces Analysis o Five forces summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Application o Market segments o Comparison by Application o Biomarker and drug discovery - Market size and forecast 2019-2024 o Nutrigenomics - Market size and forecast 2019-2024 o Toxicology testing - Market size and forecast 2019-2024 o Market opportunity by Application • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o Asia - Market size and forecast 2019-2024 o ROW - Market size and forecast 2019-2024 o Key leading countries o Market opportunity by geography o Volume driver-Demand led growth o Market challenges o Market trends • Vendor Landscape o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Agilent Technologies Inc. o Bio-Rad Laboratories Inc. o Bruker Corp. o Danaher Corp. o Human Metabolome Technologies Inc. o Metabolomic Technologies Inc. o Metabolon Inc. o Shimadzu Corp. o Thermo Fisher Scientific Inc. o Waters Corp. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibit • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2019 - 2024 ($ million) • 13: Global market: Year-over-year growth 2019 - 2024 (%) • 14: Five forces analysis 2019 & 2024 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2019 • 21: Application - Market share 2019-2024 (%) • 22: Comparison by Application • 23: Biomarker and drug discovery - Market size and forecast 2019-2024 ($ million) • 24: Biomarker and drug discovery - Year-over-year growth 2019-2024 (%) • 25: Nutrigenomics - Market size and forecast 2019-2024 ($ million) • 26: Nutrigenomics - Year-over-year growth 2019-2024 (%) • 27: Toxicology testing - Market size and forecast 2019-2024 ($ million) • 28: Toxicology testing - Year-over-year growth 2019-2024 (%) • 29: Market opportunity by Application • 30: Customer landscape • 31: Market share by geography 2019-2024 (%) • 32: Geographic comparison • 33: North America - Market size and forecast 2019-2024 ($ million) • 34: North America - Year-over-year growth 2019-2024 (%) • 35: Europe - Market size and forecast 2019-2024 ($ million) • 36: Europe - Year-over-year growth 2019-2024 (%) • 37: Asia - Market size and forecast 2019-2024 ($ million) • 38: Asia - Year-over-year growth 2019-2024 (%) • 39: ROW - Market size and forecast 2019-2024 ($ million) • 40: ROW - Year-over-year growth 2019-2024 (%) • 41: Key leading countries • 42: Market opportunity by geography ($ million) • 43: Impact of drivers and challenges • 44: Vendor landscape • 45: Landscape disruption • 46: Industry risks • 47: Vendors covered • 48: Market positioning of vendors • 49: Agilent Technologies Inc. - Overview • 50: Agilent Technologies Inc. - Business segments • 51: Agilent Technologies Inc. - Key offerings • 52: Agilent Technologies Inc. - Key customers • 53: Agilent Technologies Inc. - Segment focus • 54: Bio-Rad Laboratories Inc. - Overview • 55: Bio-Rad Laboratories Inc. - Business segments • 56: Bio-Rad Laboratories Inc. - Key offerings • 57: Bio-Rad Laboratories Inc. - Key customers • 58: Bio-Rad Laboratories Inc. - Segment focus • 59: Bruker Corp. - Overview • 60: Bruker Corp. - Business segments • 61: Bruker Corp. - Key offerings • 62: Bruker Corp. - Key customers • 63: Bruker Corp. - Segment focus • 64: Danaher Corp. - Overview • 65: Danaher Corp. - Business segments • 66: Danaher Corp. - Key offerings • 67: Danaher Corp. - Key customers • 68: Danaher Corp. - Segment focus • 69: Human Metabolome Technologies Inc. - Overview • 70: Human Metabolome Technologies Inc. - Product and service • 71: Human Metabolome Technologies Inc. - Key offerings • 72: Human Metabolome Technologies Inc. - Key customers • 73: Human Metabolome Technologies Inc. - Segment focus • 74: Metabolomic Technologies Inc. - Overview • 75: Metabolomic Technologies Inc. - Product and service • 76: Metabolomic Technologies Inc. - Key offerings • 77: Metabolomic Technologies Inc. - Key customers • 78: Metabolomic Technologies Inc. - Segment focus • 79: Metabolon Inc. - Overview • 80: Metabolon Inc. - Product and service • 81: Metabolon Inc. - Key offerings • 82: Metabolon Inc. - Key customers • 83: Metabolon Inc. - Segment focus • 84: Shimadzu Corp. - Overview • 85: Shimadzu Corp. - Business segments • 86: Shimadzu Corp. - Key offerings • 87: Shimadzu Corp. - Key customers • 88: Shimadzu Corp. - Segment focus • 89: Thermo Fisher Scientific Inc. - Overview • 90: Thermo Fisher Scientific Inc. - Business segments • 91: Thermo Fisher Scientific Inc. - Key offerings • 92: Thermo Fisher Scientific Inc. - Key customers • 93: Thermo Fisher Scientific Inc. - Segment focus • 94: Waters Corp. - Overview • 95: Waters Corp. - Business segments • 96: Waters Corp. - Key offerings • 97: Waters Corp. - Key customers • 98: Waters Corp. - Segment focus • 99: Currency conversion rates for US$ • 100: Research Methodology • 101: Validation techniques employed for market sizing • 102: Information sources • 103: List of abbreviations

Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corp., Danaher Corp., Human Metabolome Technologies Inc., Metabolomic Technologies Inc., Metabolon Inc. , Shimadzu Corp., Thermo Fisher Scientific Inc., Waters Corp.